ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Carcinoma, Renal Cell is on this study

  • ClinicalTrials.gov files the study under Carcinoma, Renal Cell.
  • Rule based: the finest condition the study states.
7 links0 made here, not in the record7 judgments1 judge (the rules as one: Rule based)2 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT07863024Safety and Efficacy Studyin Adults With AdvancedSolid Tumors ReceivingREGN13089-M404-M2980, anAntibody-drug ConjugateThat Targets MET Protein onTumorsRegeneron PharmaceuticalsPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSCarcinoma, Renal CellThe registry's MeSH filing›Nov 19 · Rule based · Finest filed termFinest filed termColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termNeoplasm MetastasisThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termUveal MelanomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT032846Entry “REGN13089-M404-M2980”, read by…›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
2 versions of the record seen on ClinicalTrials.gov, Oct 7–Nov 18 · changes seen, not judgments
Nov 14Colorectal NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Stomach NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Neoplasm MetastasisRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Uveal MelanomaRule based · condition-kind ruleFinest filed termCurrent
Nov 19Carcinoma, Renal CellRule based · condition-kind ruleFinest filed termCurrent
As of nowINT032846Rule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.